IBM is no stranger to blockchain technology, with all the company focusing on a few different projects by using the innovative decentralized ledger. In line with new reports, the tech giant is already partnering together with the Centers for Disease Control to fight the ongoing opioid crisis, among other illness.

Streamlining Medical Records

The two work on a new blockchain-based platform that streamlines the CDC’s are employed surveying medical providers. Their system has long been tested via simulated data, together with the distributed ledger autonomously collecting and securing information.

As reported by Fast Company, the CDC already collects data from multiple surveys just like the National Ambulatory Expenses Survey and the National Hospital Ambulatory Expenses Survey. Accumulated information reveals many how often patients check-in for care,?in the number of opioid prescriptions doctors provide. Blockchain technology presents a better way to see that info while the ability to track that is using it and when.

However, it’s important to keep in mind that this blockchain won’t store information. Instead, data would be stored on IBM’s cloud servers, with the blockchain authorizing those that deserve access, determined by IBM’s blockchain technical lead, David McElroy.

A Change of Heart

Ironically, cryptocurrencies and blockchain have often been charged with worsening the opioid outbreak, simply because of the more anonymous nature of buying a product via digital assets. Yet, these good-hearted groups are functioning to change that stereotype.

According to HealthcareITNews, the CDC has delved into a good number of different blockchain projects, and this recent collaboration shojuld not be a surprise. Intel is as well working with blockchain to counteract opioid abuse, as reported by Bloomberg.

The goal with of these groups is ty trying the decentralized ledger to how often medicine is distributed where it goes. Ideally, all healthcare providers and companies would collaborate relating to the blockchain so the CDC can prevent patients who visit multiple doctors or jump state borders from acquiring more prescriptions.

Unfortunately, there is no date for widespread deployment, yet it is great to find out big tech pushing because of types of use case.